Added to YB: 2017-06-09
Pitch date: 2017-06-09
PTLA:US [bearish]
Portola Pharmaceuticals, Inc.
+63.49%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Portola Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops and commercializes novel therapeutics in the areas of thrombosis and other hematologic disorders and inflammation in Europe and the United States.
Market Cap
$1.4B
Pitch Price
$49.38
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-4.76
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Portola Pharmaceuticals Inc PTLA:US
A summary for this pitch has not been created yet.
Read full article (0 min)